Logo for: PursueCare

PursueCare’s Dr. Jason Kirby Honored as 2025 Distinguished Fellow by the American Society of Addiction Medicine

December 5, 2024 MIDDLETOWN, CT—PursueCare, virtual addiction treatment provider, announced today that Dr. Jason Kirby, DO, MBA, DFASAM, Medical Director, has been awarded the 2025 Distinguished Fellow of the American Society of Addiction Medicine (ASAM) designation. This prestigious recognition underscores Dr. Kirby’s commitment to advancing...

PursueCare to Participate in Behavioral Health Tech Conference 2024 Panel on Regulatory Shifts in Substance Use Disorder Treatment

November 1, 2024 MIDDLETOWN, CT—PursueCare, an innovative leader in virtual addiction treatment, will join a panel of industry experts to discuss the pressing need to address regulations impacting substance use disorder (SUD) treatment at the upcoming Behavioral Health Tech (BHT 2024) Conference. Held at the...

PursueCare Recognized as “Rising Star” in Mental and Behavioral Health at the Digital Health Hub Awards, Presented @HLTH Conference 2024

October 22, 2024 MIDDLETOWN, CT—PursueCare, a virtual addiction treatment provider, announced today that it has been awarded the prestigious “Rising Star” award for Mental and Behavioral Health by the Digital Health Hub Foundation at this year’s HLTH USA conference in Las Vegas. The Digital Health Hub Foundation...

PursueCare Introduces RESET® and RESET-O®—FDA-Authorized Digital Therapeutics for Addiction Treatment

October 16, 2024, 10 AM EST MIDDLETOWN, CT—(BUSINESS WIRE)—PursueCare, a leader in virtual addiction treatment, today announced the rollout of RESET® and RESET-O®, the only FDA-authorized prescription digital therapeutics (PDTs) for substance use disorder (SUD) and opioid use disorder (OUD). The groundbreaking app-based digital therapies...